{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T20:32:59Z","timestamp":1784752379736,"version":"3.55.0"},"reference-count":10,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","trasci.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transfusion and Apheresis Science"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.transci.2020.102883","type":"journal-article","created":{"date-parts":[[2020,7,22]],"date-time":"2020-07-22T12:05:55Z","timestamp":1595419555000},"page":"102883","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Thrombocytopenia due to rivaroxaban: A rare adverse effect"],"prefix":"10.1016","volume":"59","author":[{"given":"Mesut","family":"T\u0131\u011fl\u0131o\u011flu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P\u0131nar","family":"Akyol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bu\u011fra","family":"Sa\u011flam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merih Reis","family":"Aras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hacer Berna","family":"Afacan \u00d6zt\u00fcrk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulkerim","family":"Y\u0131ld\u0131z","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murat","family":"Albayrak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.transci.2020.102883_bib0005","series-title":"Efficacy and toxicity of factor Xa inhibitors","author":"Bondarenko","year":"2013"},{"key":"10.1016\/j.transci.2020.102883_bib0010","doi-asserted-by":"crossref","first-page":"e108","DOI":"10.5114\/amsad.2017.72533","article-title":"Non-hemorrhage-related adverse effects of rivaroxaban. Archives of medical sciences","volume":"2","author":"Christopoulou","year":"2017","journal-title":"Atherosclerotic Dis"},{"issue":"suppl._1","key":"10.1016\/j.transci.2020.102883_bib0015","first-page":"A13824","article-title":"Oral anticoagulants and risk of liver injury in patients with atrial fibrillation: a prospective study","volume":"134","author":"Alonso","year":"2016","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.transci.2020.102883_bib0020","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/s40629-015-0048-2","article-title":"Hypersensitivity reactions to modern antiplatelet and anticoagulant drugs","volume":"24","author":"Hofmeier","year":"2015","journal-title":"Allergo J Int"},{"issue":"21","key":"10.1016\/j.transci.2020.102883_bib0025","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.2169\/internalmedicine.53.2890","article-title":"Acute thrombocytopenia after initiating anticoagulation with rivaroxaban","volume":"53","author":"Mima","year":"2014","journal-title":"Intern Med"},{"issue":"3","key":"10.1016\/j.transci.2020.102883_bib0030","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.ajem.2017.12.052","article-title":"Drug-induced thrombocytopenia after anticoagulation with rivaroxaban","volume":"36","author":"Pop","year":"2018","journal-title":"Am J Emerg Med"},{"issue":"12","key":"10.1016\/j.transci.2020.102883_bib0035","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1007\/s00228-005-0043-5","article-title":"Safety, pharmacodynamics, and pharmacokinetics of BAY 59-7939\u2014an oral, direct Factor Xa inhibitor\u2014after multiple dosing in healthy male subjects","volume":"61","author":"Kubitza","year":"2005","journal-title":"Eur J Clin Pharmacol"},{"issue":"6","key":"10.1016\/j.transci.2020.102883_bib0040","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1111\/j.1538-7836.2009.03360.x","article-title":"Drug\u2010induced immune thrombocytopenia: pathogenesis, diagnosis, and management","volume":"7","author":"Aster","year":"2009","journal-title":"J Thromb Haemost"},{"issue":"1","key":"10.1016\/j.transci.2020.102883_bib0045","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/jth.12052","article-title":"A systematic evaluation of laboratory testing for drug\u2010induced immune thrombocytopenia","volume":"11","author":"Arnold","year":"2013","journal-title":"J Thromb Haemost"},{"issue":"2","key":"10.1016\/j.transci.2020.102883_bib0050","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/clpt.1981.154","article-title":"A method for estimating the probability of adverse drug reactions","volume":"30","author":"Naranjo","year":"1981","journal-title":"Clin Pharmacol Ther"}],"container-title":["Transfusion and Apheresis Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050220301889?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050220301889?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T08:53:17Z","timestamp":1761468797000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1473050220301889"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":10,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["S1473050220301889"],"URL":"https:\/\/doi.org\/10.1016\/j.transci.2020.102883","relation":{},"ISSN":["1473-0502"],"issn-type":[{"value":"1473-0502","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Thrombocytopenia due to rivaroxaban: A rare adverse effect","name":"articletitle","label":"Article Title"},{"value":"Transfusion and Apheresis Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transci.2020.102883","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102883"}}